 Your new post is loading...
 Your new post is loading...
|
Scooped by
Gilbert C FAURE
July 25, 2012 11:13 AM
|
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
Scooped by
Gilbert C FAURE
July 25, 2012 9:00 AM
|
Oncology Medical Article: Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus/sirolimus-based GVHD prophylaxis (Reduced intensity allogeneic hematopoietic stem cell transplantation for MDS using tacrolimus...)...
|
Scooped by
Gilbert C FAURE
July 25, 2012 4:55 AM
|
PubMed comprises more than 21 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.
|
Scooped by
Gilbert C FAURE
July 25, 2012 3:49 AM
|
New guidelines now urge adults who have been infected with HIV to start taking HIV-fighting drugs as soon as possible, ideally within two weeks of being diagnosed with the infection, rather than waiting to see what happens with white blood cell...
|
Scooped by
Gilbert C FAURE
July 25, 2012 3:48 AM
|
20000000. This is the number of peripheral artery disease patients Pluristem Therapeutics, a placenta-based cell therapy company, is working to assist. The company recently released information regarding the effectiveness of cell therapy ...
|
Scooped by
Gilbert C FAURE
July 24, 2012 1:23 PM
|
Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recur http://t.co/KEVBD7kb...
|
Scooped by
Gilbert C FAURE
July 24, 2012 11:28 AM
|
Free Article: Intraspinal Stem Cell Transplantation. leave a comment ». Background: No United States-based clinical trials have attempted delivery of biological therapies directly to the spinal cord for treatment of amyotrophic ...
|
Scooped by
Gilbert C FAURE
July 24, 2012 7:14 AM
|
DGAP-News: SuppreMol GmbH / Key word(s): StudySuppreMol GmbH: SuppreMol begins development of Anti-IL-3 monoclonalantibody to diagnose and treat early stage Rheumatoid Arthritis24.07.2012 /...
|
Scooped by
Gilbert C FAURE
July 23, 2012 1:44 PM
|
Antibody therapy may stabilize early Alzheimer’s symptoms > Facts & Fears > ACSH via @rosie_ms: Antibody therapy may...
|
Scooped by
Gilbert C FAURE
July 23, 2012 7:19 AM
|
CytoDyn (Other OTC:CYDY.PK - News) is a development stage biotech company focused on the discovery and development of novel anti-HIV and anti-FIV agents. The Company holds two proprietary platform technologies: Cytolin, a ...
|
Scooped by
Gilbert C FAURE
July 20, 2012 3:37 PM
|
Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy (#clinicaltrials Biotest’s Antibody-drug Conjugate BT-062 In Multiple Myeloma Combination Therapy: BT-062, an ant...)...
|
Scooped by
Gilbert C FAURE
July 20, 2012 3:35 PM
|
Background: No United States-based clinical trials have attempted delivery of biological therapies directly to the spinal cord for treatment of amyotrophic lateral sclerosis (ALS) because of the lack of a meaningful US Food and Drug...
|
Scooped by
Gilbert C FAURE
July 20, 2012 3:30 PM
|
Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Prev...
|
|
Scooped by
Gilbert C FAURE
July 25, 2012 9:05 AM
|
To date, few fundamentals have been known about the most common gland in the body, the sweat glands that are essential to controlling body temperature, allowing humans to live in the world’s diverse climates.
|
Scooped by
Gilbert C FAURE
July 25, 2012 8:59 AM
|
Uploaded and shared in Youtube by: ymbiosciences —Nimotuzumab is a humanized monoclonal antibody that targets and binds to the epidermal growth factor receptor (EGFR).
|
Scooped by
Gilbert C FAURE
July 25, 2012 4:54 AM
|
|
Scooped by
Gilbert C FAURE
July 25, 2012 3:49 AM
|
Researchers discover new target for vaccine development in abundant immune ...Medical XpressResearchers evaluated healthy human tissues key to the immune system to assess the abundance of neutrophils in the lymph nodes, tonsils, lymphoid tissue in...
|
Scooped by
Gilbert C FAURE
July 24, 2012 1:24 PM
|
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagno...
|
Rescooped by
Gilbert C FAURE
from Immune-Monitoring
July 24, 2012 1:21 PM
|
|
Scooped by
Gilbert C FAURE
July 24, 2012 7:15 AM
|
SAN DIEGO, CA -- (Marketwire) -- 07/24/12 -- Aegis Therapeutics LLC announced today that it has been awarded U.S. Patent No. 8,226,949 providing broad protection for stabilized formulations of monoclonal antibodies.
|
Scooped by
Gilbert C FAURE
July 24, 2012 4:24 AM
|
Damaged and aged heart tissue of older heart failure patients was rejuvenated by stem cells modified by scientists, according to research presented at the Ameri (RT @AGE: New stem cell therapy succesfully rejuvenates aging heart muscle cells in humans.)...
|
Scooped by
Gilbert C FAURE
July 23, 2012 1:43 PM
|
Conditions : Neuroblastoma; Melanoma; Osteosarcoma Intervention : Biological: Anti-G2 antibody Sponsors : St. Jude Children's Research Hospital; St. Jude Children's Research Hospital; Evan T. J. Dunbar Neuroblastoma Foundation, Inc.;...
|
Scooped by
Gilbert C FAURE
July 21, 2012 11:08 AM
|
In this Eureka Podcast Episode, Shawna Jackman, Senior Research Scientist at Charles River, provides her top 10 tips to consider when designing a translational cell therapy preclinical program.
|
Scooped by
Gilbert C FAURE
July 20, 2012 3:36 PM
|
ODYSSEY, a global program to evaluate SAR236553 REGN727, a potential first-in-class PCSK9 inhibitor, will comprise over ten clinical trials and will include mor (Sanofi and Regeneron Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering...
|
Scooped by
Gilbert C FAURE
July 20, 2012 3:30 PM
|
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute My...
|